You are here

Novo Nordisk

Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill

BioSpace

Mon, 05/5/25 - 11:29 am

Wegovy treated a serious form of liver disease in a major clinical trial

NBC News

Mon, 05/5/25 - 11:06 am

clinical trials

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans

CNBC

Thu, 05/1/25 - 11:10 am

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%

CNBC

Tue, 04/29/25 - 08:23 am

Hims & Hers Health

US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide

Fierce Pharma

Fri, 04/25/25 - 11:32 am

drug compounding

Novo says it’s submitted obesity pill for FDA approval

BioPharma Dive

Mon, 04/21/25 - 06:13 pm

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts

Fierce Pharma

Thu, 04/17/25 - 11:06 pm

BMO Capital Markets

Novo Nordisk warns consumers about counterfeit versions of Ozempic in US

Investing.com

Mon, 04/14/25 - 07:19 pm

drug counterfeiting

Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil

Yahoo Finance

Wed, 04/9/25 - 11:18 am

drug manufacturing

HHS leaves door open to future Medicare coverage of obesity drugs

BioSpace

Tue, 04/8/25 - 11:54 am

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC

Sun, 04/6/25 - 11:40 pm

Novo Holdings nearly doubles earnings as Wegovy swells coffers

Yahoo/Reuters

Wed, 04/2/25 - 11:43 am

ACC25: Ozempic shows its value in PAD

Pharmaphorum

Mon, 03/31/25 - 10:03 am

type 2 diabetes

Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide

Fierce Biotech

Fri, 03/28/25 - 11:24 am

Lexicon Pharmaceuticals

BofA cuts Novo Nordisk shares target on expected Q1 earnings miss

Yahoo Finance

Fri, 03/28/25 - 11:22 am

Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks

Fierce Biotech

Mon, 03/24/25 - 11:20 am

United Laboratories

triple G agonists

Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy

Fierce Pharma

Mon, 03/24/25 - 11:05 am

NovoCare Pharmacy

Brazil's Hypera to launch an Ozempic generic in 2026, CEO says

MSN/Reuters

Mon, 03/24/25 - 11:02 am

Pages